- CEO
- Floretta Gogo
- Full Time Employees
- 3
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Address
- 650 Ponce De Leon Ave Atlanta GA United States of America 30308
- IPO Date
- Mar 17, 2025
- Business
- The Cannaisseur Group, Inc. (OTC Pink: TCRG) operates as a wellness company focused on developing and distributing science-backed functional products in the health, nutraceuticals, and sustainable hemp sectors; its core offerings include functional beverages, nutraceuticals, consumer goods, and CBD wellness products such as drops, tinctures, oil capsules, concentrates, edibles, pet oils, lotions, balms, vape oils, vaporizers, and raw CBD hemp extract under brands including Alchemy Naturals, Bluebird Botanicals, CBD Living, Chill, Enjoy Hemp, Hemplucid, Original Hemp, and Rare Cannabinoid Company. The company conducts business primarily through its 51%-owned subsidiary Atlanta CBD, Inc., a hemp products supplier and retailer operating under the Inno Medicinals trade name in Atlanta, Georgia; it engages in hemp cultivation, extraction, manufacturing, distribution, and direct-to-consumer sales via its website, targeting patients, physicians, pharmacies, hospitals, governments, and researchers across five continents. Founded on December 22, 2020, and headquartered at 650 Ponce de Leon Ave NE, Suite 300 #2334, Atlanta, Georgia 30308, the company serves the medicinal chemicals, botanical products, and personal care industries with an emphasis on functional nutrition, hydration solutions, and eco-conscious principles.
In recent developments, The Cannaisseur Group completed a $35 million asset acquisition in August 2025 encompassing sensor technologies, agricultural manufacturing, nutrition infrastructure, real estate, equipment, and intellectual property in soy processing, sustainable agriculture, and industrial automation, transitioning from a non-operational entity to a revenue-generating platform under incoming CEO Bruce Schreiner while assuming approximately $500,000 in debt and targeting OTCQB uplisting. Earlier in April 2025, it executed a letter of intent for the acquisition, formed a transition team in late April to support the deal, and amended its authorized share capital to 500 million shares in March to facilitate growth. The company officially listed on the OTC Pink market in early 2025, marking its public debut amid strategic shifts from cannabis and hemp operations toward diversified AgTech, sensor-based security, networking solutions, and broader wellness innovation.